Search results
Results from the WOW.Com Content Network
Portola Pharmaceuticals is an American clinical stage biotechnology company that researches, develops, and commercializes drugs. The company focuses primarily on drugs used in the treatment of thrombosis and hematological malignancies . [ 2 ]
Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. [1] It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK.
Andexxa (Andexanet alfa) from Portola Pharmaceuticals is a recombinant protein that is given intravenously. It works as an antidote to all direct and indirect FXa inhibitors. Andexxa acts as a decoy receptor for Xa inhibitors.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The substance was originally developed by Portola Pharmaceuticals, with Phase II clinical trials conducted around 2008–2011. [4] In February 2009, Novartis bought worldwide rights to develop it further, intending to conduct Phase III studies and commercialise the drug. [5] The development of the drug was terminated in January 2012 by Novartis ...
A. Abbott Laboratories; AbbVie; Acadia Pharmaceuticals; Acceleron Pharma; Acorda Therapeutics; ACT Biotech Inc; Acura Pharmaceuticals; Aerie Pharmaceuticals; Agios ...
Poker: Texas Hold'em (No Limit) Play two face down cards and the five community cards. Bet any amount or go all-in. By Masque Publishing
Ian Gibbons (March 6, 1946 – May 23, 2013) was a British biochemist and molecular biology researcher who served as the chief scientist of the US company Theranos, which was founded by Elizabeth Holmes.